Амезопан - analogs
Components: Pazopanib |
|||||||||
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
Prices in pharmacies: — Instructions Амезопан | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . Антиандрен депо ✘ (incl) Активатор кальция ✘ (incl) Остеозамин ✘ (incl) Nilmatrelvir+Ritonavir (set) ✘ (incl) Iso Mack spray ✘ (incl) Carnitine ✘ (incl) Spasmocystenal ✘ (incl) Feldoral SEDICO ✘ (incl) Polypeptides of testes of cattle ✘ (incl) Kali phosphoricum ✘ (incl) Ovi meleagris vitellus ✘ (incl) NOW Choline and Inositol ✘ (incl) Collagenics ✘ (incl) Novosept Forte ✘ (incl) Доппельгерц актив Фито ОМЕГА-3 из льна и водорослей ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Similar | Complete analog ⓘ✘Аналоги препарата с полностью совпадающими действующими веществами |
Prices in pharmacies |
≈100% | Votrient neutral | 882-1043.3€ |
≈100% | Pazopanib neutral | — |
≈100% | Pazopanib-TL neutral | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 58% — Sunitinib neutral [Sunitinib]
- 56% 153.1-1937.3€ Sutent neutral [Sunitinib]
- 42% 830-1485.8€ Nexavar neutral [Sorafenib]
- 42% — Сорафениба тозилат neutral [Sorafenib]
- 42% — Сорафениб-натив neutral [Sorafenib]
- 42% — Сорафениб геми-тозилат моногидрат neutral [Sorafenib]
- 42% — Сорафениб-АМЕДАРТ neutral [Sorafenib]
- 42% — Сорафениб-промомед neutral [Sorafenib]
- 42% — Флутриксан neutral [Sorafenib]
- 41% 1732.5€ Lenvima neutral [Lenvatinib]
- 40% 1685.1€ Yondelis neutral [Trabectedin]
- 39% — Imatinib Negative 🔍 [Imatinib]
- 39% 3936.6€ Кабометикс neutral [Cabozantinib]
- 39% — Иматиниб-Сигардис Negative 🔍 [Imatinib]
- 39% — Албитиниб Negative 🔍 [Imatinib]
- 37% — Sorafenib neutral [Sorafenib]
- 36% 42.3-61€ Philachromin FS Negative 🔍 [Imatinib]
- 36% 2016.2€ Sunitinib-nativ neutral [Sunitinib]
- 36% 114.4-127.7€ Glivec Negative 🔍 [Imatinib]
- 33% — Сунитиниба малат neutral [Sunitinib]
- 29% — Tamoxifen-Ebewe Negative 🔍 [Tamoxifen]
- 29% 13.3-426€ Bevacizumab neutral [Bevacizumab]
- 29% — Версаво neutral [Bevacizumab]
- 29% 80-300€ Авегра БИОКАД neutral [Bevacizumab]
- 28% 363.3-1164.9€ Afinitor neutral [Everolimus and more 1Butylated hydroxytoluene]
- 26% 4850€ Imbruvica neutral [Ibrutinib]
- 25% 296€ Halaven neutral [Eribulin]
- 25% 291.9-1935.3€ Inlyta neutral [Axitinib]
- 25% 590-1010€ Zelboraf neutral [Vemurafenib and more 1Hypromellose]
- 24% — Gallium citrate, 67Ga neutral [Gallium [67Ga] citrate]
- 24% 89.9-339.6€ Avastin neutral [Bevacizumab]
- 24% 862.9€ Vargatef neutral [Nintedanib]
- 24% — Цитонибонко Negative 🔍 [Imatinib]
- 24% 605€ Imatib Negative 🔍 [Imatinib]
- 24% — Imatinib Grindex Negative 🔍 [Imatinib]
- 24% — Глемихиб Negative 🔍 [Imatinib]
- 24% — Imatinib-TL Negative 🔍 [Imatinib]
- 24% — Imvec Negative 🔍 [Imatinib]
- 24% 271€ Neopax Negative 🔍 [Imatinib]
- 24% — Imatinib-Teva Negative 🔍 [Imatinib]
- 24% — Imatinib Dr. Reddy s Negative 🔍 [Imatinib]
- 22% — Erlotinib neutral [Erlotinib]
- 22% 118€ Cosmegen neutral [Dactinomycin]
- 21% 16.9-41.2€ Natriofolin medac neutral [Folinic acid]
- 21% — Дазатиниб neutral [Dasatinib]
- 21% 1.3-2.1€ Milurit neutral [Allopurinol]
- 21% 21.3-27.4€ Азурикс neutral [Febuxostat]
- 21% — Фебуксостат neutral [Febuxostat]
- 21% 9€ Фебуксостат-СЗ neutral [Febuxostat]
- 21% — Verzenio neutral [Abemaciclib]
Learn more about the selection of analogues
- The drug has «Амезопан» 5 full analogs, the cheapest - Votrient (882-1043.3€); 51 analog by action, the most similar - Sutent (153.1-1937.3€).
- Medical online service has selected the best substitutes for Амезопан based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Амезопан analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.